Keros Therapeutics Inc (KROS) Implied Volatility Current

Tracking KROS implied volatility helps you identify when options premiums on Keros Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Keros Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when KROS IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Keros Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For KROS, tracking metrics like KROS IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on KROS signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, and is currently in Phase 1 clinical trial; and KER-012, which is in Phase 1 clinical trial to treat disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension.

The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where KROS implied volatility sits today versus where it has been. Our scanner ranks Keros Therapeutics Inc implied volatility against its historical range, surfaces extremes in KROS IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Keros Therapeutics Inc IV is rich or cheap — measure it, then act on it.